235 related articles for article (PubMed ID: 35563673)
1. The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563673
[TBL] [Abstract][Full Text] [Related]
2. RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation.
Wu Y; Ma L; Cai S; Zhuang Z; Zhao Z; Jin S; Xie W; Zhou L; Zhang L; Zhao J; Cui J
Signal Transduct Target Ther; 2021 Apr; 6(1):167. PubMed ID: 33895773
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 ORF3a positively regulates NF-κB activity by enhancing IKKβ-NEMO interaction.
Nie Y; Mou L; Long Q; Deng D; Hu R; Cheng J; Wu J
Virus Res; 2023 Apr; 328():199086. PubMed ID: 36894068
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation.
Nishitsuji H; Iwahori S; Ohmori M; Shimotohno K; Murata T
mBio; 2022 Aug; 13(4):e0097122. PubMed ID: 35856559
[TBL] [Abstract][Full Text] [Related]
5. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
Xiang J; Lu M; Shi M; Cheng X; Kwakwa KA; Davis JL; Su X; Bakewell SJ; Zhang Y; Fontana F; Xu Y; Veis DJ; DiPersio JF; Ratner L; Sanderson RD; Noseda A; Mollah S; Li J; Weilbaecher KN
J Virol; 2022 Apr; 96(7):e0005722. PubMed ID: 35319225
[TBL] [Abstract][Full Text] [Related]
6. NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors.
Kandasamy M
Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):561-567. PubMed ID: 33394134
[TBL] [Abstract][Full Text] [Related]
7. The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection.
Kesika P; Thangaleela S; Sisubalan N; Radha A; Sivamaruthi BS; Chaiyasut C
Pathogens; 2024 Feb; 13(2):. PubMed ID: 38392902
[TBL] [Abstract][Full Text] [Related]
8. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
Ma Q; Pan W; Li R; Liu B; Li C; Xie Y; Wang Z; Zhao J; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Yang Z
Pharmacol Res; 2020 Aug; 158():104850. PubMed ID: 32360580
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 ORF3a-Mediated NF-κB Activation Is Not Dependent on TRAF-Binding Sequence.
Busscher BM; Befekadu HB; Liu Z; Xiao TS
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005906
[TBL] [Abstract][Full Text] [Related]
10. The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.
Hemmat N; Asadzadeh Z; Ahangar NK; Alemohammad H; Najafzadeh B; Derakhshani A; Baghbanzadeh A; Baghi HB; Javadrashid D; Najafi S; Ar Gouilh M; Baradaran B
Arch Virol; 2021 Mar; 166(3):675-696. PubMed ID: 33462671
[TBL] [Abstract][Full Text] [Related]
11. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.
Su CM; Wang L; Yoo D
Sci Rep; 2021 Jun; 11(1):13464. PubMed ID: 34188167
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling.
Li TW; Kenney AD; Park JG; Fiches GN; Liu H; Zhou D; Biswas A; Zhao W; Que J; Santoso N; Martinez-Sobrido L; Yount JS; Zhu J
Front Immunol; 2022; 13():1007089. PubMed ID: 36177032
[TBL] [Abstract][Full Text] [Related]
13. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19.
Attiq A; Yao LJ; Afzal S; Khan MA
Int Immunopharmacol; 2021 Dec; 101(Pt B):108255. PubMed ID: 34688149
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Nsp2 Contributes to Inflammation by Activating NF-κB.
Lacasse É; Gudimard L; Dubuc I; Gravel A; Allaeys I; Boilard É; Flamand L
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851549
[TBL] [Abstract][Full Text] [Related]
15. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling.
Robles JP; Zamora M; Adan-Castro E; Siqueiros-Marquez L; Martinez de la Escalera G; Clapp C
J Biol Chem; 2022 Mar; 298(3):101695. PubMed ID: 35143839
[TBL] [Abstract][Full Text] [Related]
16. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
Hariharan A; Hakeem AR; Radhakrishnan S; Reddy MS; Rela M
Inflammopharmacology; 2021 Feb; 29(1):91-100. PubMed ID: 33159646
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor NF-κB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model.
Kanan T; Kanan D; Al Shardoub EJ; Durdagi S
J Mol Graph Model; 2021 Nov; 108():107968. PubMed ID: 34311260
[TBL] [Abstract][Full Text] [Related]
18. The role of SARS-CoV-2-mediated NF-κB activation in COVID-19 patients.
Zhou Q; Zhang L; Dong Y; Wang Y; Zhang B; Zhou S; Huang Q; Wu T; Chen G
Hypertens Res; 2024 Feb; 47(2):375-384. PubMed ID: 37872376
[TBL] [Abstract][Full Text] [Related]
19. The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease.
Davies DA; Adlimoghaddam A; Albensi BC
Mol Neurobiol; 2021 Aug; 58(8):4178-4187. PubMed ID: 34075562
[TBL] [Abstract][Full Text] [Related]
20. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
